Joba Network Receives Funding from Decima Fund
Joba Network, a Tokyo, Japan-based Web3 startup utilizing verified identities, received an investment from Decimal Fund.
Joba Network, a Tokyo, Japan-based Web3 startup utilizing verified identities, received an investment from Decimal Fund.
Spiber, a Tsuruoka, Japan-based biomanufacturing startup, raised over JPY 10 Billion in funding.
Smartpay, a Tokyo, Japan-based digital embedded finance startup, raised $7m in a pre-Series A funding round.
Accenture (NYSE: ACN) is to acquire Climb, a Japanese technology services provider specializing in system integration, IT infrastructure management and operations, primarily in the Gunma Prefecture.
Facewhite Co., Ltd., a Tokyo, Japan-based company involved in planning and production of Chinese-Japanese coproduction film projects, completed a Pre-A financing round.
Yuurea, a Nagoya, Japan-based company that develops test kits which will allow people to monitor their physical condition using urine samples, received an investment from Toyoda Gosei (TOKYO:7282).
Tsubame BHB, a Yokohama, Japan-based company which works for the social implementation and commercialization of small, distributed ammonia production plants, raised 5.3 Billion yen in Series C funding.
Azul Energy, a Sendai, Japan-based clean chemistry startup, raised $3.2M in Series A funding.
PRISM BioLab, a Tokyo, Japan-based discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, raised 1.5 Billion Yen ($10.3M) in Series C funding.
VoicePing, a Tokyio, Japan-based real-time AI voice translation solution for global corporate communication, raised $2.09m in seed funding.
Axelspace, a Tokyo, Japan-based micro-satellites technology company, raised $44M in Series D funding.
DM2C Studio, a Tokyo, Japan-based subsidiary of DMM.com, a Japanese gaming company, raised 2.3M Dollars through a token convertible bond sale from a consortium of 8 companies.
Blocksmith&Co, a Tokyo, Japan-based provider of blockchain-related development and operations, raised a 2nd angel funding.
Shinobi Therapeutics, a San Francisco, CA- and Kyoto, Japan-based biotechnology company developing a new class of immune evasive iPS-T cell therapies, closed a $51m Series A financing.
Yoii, a Tokyo, Japan-based company providing a revenue-based financing (RBF) platform, raised $5.5M in Series A funding.